If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Directorate Change

16 Oct 2019 16:11

RNS Number : 1333Q
Cenkos Securities PLC
16 October 2019
 

16 October 2019

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 ("MAR").

 

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Directorate Change

 

The Board of Cenkos is pleased to announce the appointment of Julian Morse, as an Executive Director of the Company. This appointment is subject to Financial Conduct Authority approval and will take effect on the receipt of regulatory consent.

 

Julian is Head of the Cenkos Growth Companies Team and has led that team since 2016. He is one of the founding members of the team having joined Cenkos in 2006. He has over 25 years' experience in the City where he has advised and raised equity on IPO's and secondary fund raisings for a wide range of companies across a broad range of sectors. Previously, Julian was a Director at Beeson Gregory and Evolution Securities.

Commenting on the appointment, Jeff Hewitt Acting Chairman of the Company, said:

"I am delighted that Julian has agreed to join the Board. With Julian's experience and proven success in managing the Growth Companies team he will provide a valuable addition to the Board and will assist in driving the whole business forward."

Additional Information

 

In accordance with the AIM Rules, the following information is required to be disclosed in relation to Julian Morse is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

 

Full Name and age:

Julian Jonathan Morse aged 48

 

Current Directorships/Partnerships:

None

 

Previous Directorships/Partnerships:

Dovemoat LLP - LLP member resigned 17 November 2015

 

Current interest in the Company's share capital:

403,239 Ordinary shares of 1 pence held under his Self-Invested Personal Pension

384,501 Ordinary shares of 1 pence held in accordance with the terms and conditions of Company's Deferred Bonus Scheme

18,842 Ordinary shares of 1 pence shares held in the Company's Share Incentive Plan of which X are subject to forfeiture

 

Options over 185,220 Ordinary shares held under the Compensatory Award Plan Options. These options are at 169.0 pence. These options expire on 22 October 2019.

 

Options over 21,094 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 85.3 pence. These options expire on 30 November 2021.

 

 

 

 

Enquiries:

 

Cenkos Securities plc

Jim Durkin, Chief Executive Officer

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

Tel: 0207 466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABUBDGRGBBGCL
Date   Source Headline
2nd Feb 202310:58 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 20239:09 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20239:22 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 202310:16 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
25th Jan 20239:22 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
24th Jan 20238:55 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20239:05 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20238:26 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20238:41 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20238:37 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 20238:45 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20239:03 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20239:08 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20238:46 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 20239:38 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20239:11 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:40 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20238:36 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20238:25 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20238:17 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:20 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20239:14 amRNSForm 8.5 (EPT/NON-RI) - TP Group PLC
30th Dec 20229:05 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20228:44 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20228:39 amRNSForm 8.5 (EPT/NON-RI)
22nd Dec 20228:56 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 20229:22 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 202211:10 amRNSForm 8.5 (EPT/NON-RI)
19th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20228:58 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 202210:26 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 202210:23 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 20229:45 amRNSForm 8.5 (EPT/NON-RI)
9th Dec 20228:46 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:36 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 20228:34 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 20221:34 pmEQSCenkos Securities sees combination of factors behind M&A slowdown
7th Dec 202210:46 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:54 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20228:51 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 202211:47 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
5th Dec 20227:00 amRNSDirectorate Change
2nd Dec 202210:09 amRNSForm 8.5 (EPT/NON-RI)
2nd Dec 202210:02 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 202210:00 amRNSForm 8.5 (EPT/NON-RI)
1st Dec 20229:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.